Allurion launches gastric balloon for weight loss

Allurion, a company dedicated to ending obesity, has launched the Allurion Swallowable Capsule in India - the only medical weight-loss device fully approved by the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority of India overseen by the Ministry of Health & Family Welfare’s Directorate General of Health Services.

Dr.Shantanu Gaur founded Allurion with one goal: end obesity. After completing his undergraduate studies at Harvard University, Dr. Gaur founded the company while completing his medical studies at Harvard Medical School in 2009. Together with his partner and former Harvard professor Dr. Ram Chuttani, he developed the vision for the Allurion Program. At the core of the Allurion Program is the Allurion Swallowable Capsule: the world’s first and only swallowable, procedureless* gastric balloon for weight loss. The Allurion Swallowable Capsule is paired with the Allurion Virtual Care Suite, a remote patient monitoring solution powered by the Allurion Iris AI platform that includes the Allurion Mobile App, Connected Scale and Health Tracker.

"As someone of Indian origin, India is a special market for Allurion.It is part of my personal mission to bring our revolutionary technology to India to help end obesity and diabetes,” says Dr Shantanu Gaur, Founder and CEO of Allurion."Whether it is because they have a wedding coming up, have steadily put on weight due to a busy or stressful lifestyle, recently had a health scare, need to improve their fertility, or need to lose weight before an operation, the Allurion Program can be the answer for millions of patients throughout India,"he adds.

At the heart of the Allurion Program is the Allurion’sVirtual Care Suite, which integrates the Allurion Mobile App, Connected Scale, and Health Trackerinto a single “digital umbrella” to provide remote patient monitoring, tele health and secure messaging with the care team. The software platform is powered by artificial intelligence and machine learning to allow care teams to interact with their patients– and their data.

The Allurion Programcan lead to 2.5 times more weight loss compared to dietor exercise alone. More importantly, it works to help patients make lifestyle changes that remain with them long after the balloon is gone.

Dr Mohit Bhandari of MohakBariatrics is a bariatric and endoscopic weight-loss surgeon, and a pioneer in offering the Allurion Program in India.“Obesity is on the rise in India with three out of every four urban Indians overweight. As one of the most experienced bariatric surgeons in the Asia Pacific region with 17,000 bariatric surgeries performed to date, I think that weight management needs to be normalized rather than stigmatized, and the Allurion Program is a positive step in that direction, ”he says.

Dr Ram Chuttani, Chief Medical Officer and Founding Partner of Allurion, adds: "Allurion is committed to provide patients a best-in-class experience, and their safety is our top priority. Studies have confirmed the proven efficacy and safety4 of the Allurion Program, helping patients lose an average 10-15% of their body weight in approximately 16 weeks1.

Benoit Chardon, Chief Commercial Officer of Allurion states: "Considering Allurion's success across markets – a result of the perfect match between the benefits delivered by our program and patient expectations – as well as the growing prevalence of obesity in India, we are confident of the potential for success with our program in the country, where our market research has shown that over a million obese people concerned and ready to act about their weight would consider Allurion."

Comments

Post a Comment

Popular posts from this blog

First DPL match was won by US Consulate Staff Team

Image
  ICWO - Indian Community Welfare Organisation  organized the First DPL- Diplomat Cricket Tournament for Embassy, Consulate & High Commission Staff on 10 th   August 2024 at Soka Ikeda College of Arts and Science for Women, Sethu Bhaskara Nagar, Madhanangkuppam, Kolathur, Chennai. T he event aims to create high level Awareness to STOP Child Abuse, Child Trafficking, Child Marriage & Child Labour in Tamilnadu and mobilize funds for intervention to address the same. A.J.Hariharan, Secretary – ICWO thanked both the US Consulate and Malaysian Consulate for their support and participation in the diplomate cricket tournament as to create an awareness about the Child Marriage, Child Trafficking & Child Labour and Child Abuse in Tamilnadu. The tournament has created huge interest among the players and the consul officials. We, ICWO have plan to organize similar event on 3 rd  May 2025. This time for men and women doubles badminton tournament. We emphasis there is...
Read more

TATA AIG Strengthens Tamil Nadu Health Insurance Portfolio with New Riders amid Strong Growth

Image
Chennai, 12 November 2024: TATA AIG General Insurance, a leading general insurance provider in India, is strengthening its health insurance offerings in Tamil Nadu with five specialised riders: Mental Wellbeing, Empower Her, OPD Care, CanCare, and Flexi Shield. These riders are specifically designed to address the unique and diverse healthcare needs of the state’s residents, providing enhanced protection in areas such as mental health, women’s health, cancer treatment, and routine medical costs. TATA AIG has established a robust presence across 31 districts in Tamil Nadu, with key branches in Chennai, Coimbatore, Madurai, Tiruchirapalli, Tirunelveli, and Salem. The company’s expansive network includes over 1000 hospitals, ensuring seamless access to cashless treatment for its customers across both urban and rural regions. With a well-established network of agents and digital platforms, the company is bringing quality health insurance solutions to every corner of the state. This pe...
Read more

Apollo Cancer Centers now introduces Made in India, CAR T Cell Program

Image
First Private Hospital in India to Successfully Complete CAR T Cell Therapy.  In a ground-breaking development, Apollo Cancer Centres (ACCs) has emerged as the first private hospital group in India to have a successfully complete CAR-T cell program and to further augment it, the group will now provide access to Made in India CAR-T cell therapy, beginning with NexCAR19 (Actalycabtagene autoleucel), for the treatment of B-cell lymphomas and B-acute lymphoblastic leukaemia in patients aged 15 years and above.   Marking a historic moment in the country's medical landscape , Dr. T Raja, Director of Medical Oncology at ACC, Chennai, spearheaded the development of this revolutionary clinical program, and has successfully treated six patients till date.   CAR-T cell therapies, often known as living drugs involve the extraction of a patients T-cells (a type of white blood cells whose function is to fight cancer cells) through a process known as Apheresis. These T-cells are t...
Read more